Clinical trial

Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease

NCT03250741

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Rotigotine transdermal patch Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE2

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

Rotigotine transdermal patchDRUG

PlaceboOTHER

Sponsors & collaborators

I.R.C.C.S. Fondazione Santa Lucialead sponsor

Mapped research locations

RomeItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03250741 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.